Device |
des-gamma-carboxy-prothrombin (dcp), risk assessment, hepatocellular carcinoma |
Definition |
The test is intended to quantitatively measure dcp in human serum and use as an aid in the risk assessment of patients with chronic liver disease for progression to hepatocellular carcinoma (hcc) in conjunction with other laboratory findings, imaging studies and clinical assessment for risk assessment of patients with chronic liver disease for progression to hepatocellular carcinoma. |
Product Code | OAU |
Regulation Number |
866.6030
|
Device Class |
2
|
|
|